Figure 6.
Figure 6. TPD52 expression in Hodgkin lymphoma. (A) Mixed cellularity Hodgkin lymphoma. Mononuclear variants show strong (arrow) and moderate (arrowhead) TPD52 positivity (original magnification × 800). (B-D) Tumor cell–rich Hodgkin lymphoma (original magnification × 400). A nodule of tumor cells (*) that are CD30+ (not shown) and CD79a- (B) displays nuclear staining for PAX5 (C) and cytoplasmic labeling for TPD52 (D). The rim of residual normal B cells at the periphery of the nodule served as positive control. Lymph node paraffin sections. The APAAP technique was used with hematoxylin counterstain.

TPD52 expression in Hodgkin lymphoma. (A) Mixed cellularity Hodgkin lymphoma. Mononuclear variants show strong (arrow) and moderate (arrowhead) TPD52 positivity (original magnification × 800). (B-D) Tumor cell–rich Hodgkin lymphoma (original magnification × 400). A nodule of tumor cells (*) that are CD30+ (not shown) and CD79a- (B) displays nuclear staining for PAX5 (C) and cytoplasmic labeling for TPD52 (D). The rim of residual normal B cells at the periphery of the nodule served as positive control. Lymph node paraffin sections. The APAAP technique was used with hematoxylin counterstain.

Close Modal

or Create an Account

Close Modal
Close Modal